Nanobiotix S.A. (0QAV.L)

EUR 3.04

(3.06%)

Operating Income Summary of Nanobiotix S.A.

Nanobiotix S.A.'s latest annual operating income in 2023 was -26.77 Million EUR , up 46.96% from previous year.
Nanobiotix S.A.'s latest quarterly operating income in 2024 Q2 was -23.65 Million EUR , down 0.0% from previous quarter.
Nanobiotix S.A. reported an annual operating income of -50.49 Million EUR in 2022, down -1.39% from previous year.
Nanobiotix S.A. reported an annual operating income of -49.8 Million EUR in 2021, down -28.05% from previous year.
Nanobiotix S.A. reported a quarterly operating income of -28.66 Million EUR for 2023 Q2, down 0.0% from previous quarter.
Nanobiotix S.A. reported a quarterly operating income of 1.13 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Operating Income Chart of Nanobiotix S.A. (2023 - 2012)

Historical Annual Operating Income of Nanobiotix S.A. (2023 - 2012)

Year	Operating Income	Operating Income Growth
2023	-26.77 Million EUR	46.96%
2022	-50.49 Million EUR	-1.39%
2021	-49.8 Million EUR	-28.05%
2020	-38.89 Million EUR	20.94%
2019	-49.19 Million EUR	-47.15%
2018	-33.43 Million EUR	-16.33%
2017	-28.73 Million EUR	-12.44%
2016	-25.55 Million EUR	-22.34%
2015	-20.89 Million EUR	-117.17%
2014	-9.61 Million EUR	-17.61%
2013	-8.17 Million EUR	-58.74%
2012	-5.15 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-23.65 Million EUR	0.0%
2023 Q2	-28.66 Million EUR	0.0%
2023 Q4	1.13 Million EUR	0.0%
2023 FY	-30.38 Million EUR	39.82%
2022 Q4	-24.24 Million EUR	0.0%
2022 FY	-50.49 Million EUR	-1.39%
2022 Q2	-26.24 Million EUR	0.0%
2021 Q4	-24.13 Million EUR	0.0%
2021 Q2	-25.67 Million EUR	0.0%
2021 FY	-49.8 Million EUR	-28.05%
2020 FY	-38.89 Million EUR	20.94%
2020 Q2	-19.9 Million EUR	0.0%
2020 Q4	-19.09 Million EUR	0.0%
2019 Q4	-26.88 Million EUR	0.0%
2019 Q2	-22.3 Million EUR	0.0%
2019 FY	-49.19 Million EUR	-47.15%
2018 FY	-33.43 Million EUR	-16.33%
2018 Q4	-17.09 Million EUR	0.0%
2018 Q2	-12.97 Million EUR	0.0%
2017 Q2	-11.8 Million EUR	0.0%
2017 FY	-28.73 Million EUR	-12.44%
2017 Q4	-13.45 Million EUR	0.0%
2016 Q2	-10.07 Million EUR	0.0%
2016 FY	-25.55 Million EUR	-22.34%
2016 Q4	-11.78 Million EUR	0.0%
2015 FY	-20.89 Million EUR	-117.17%
2015 Q4	-9.26 Million EUR	0.0%
2015 Q2	-7.87 Million EUR	0.0%
2014 FY	-9.61 Million EUR	-17.61%
2014 Q2	-4.2 Million EUR	0.0%
2014 Q4	-5.41 Million EUR	0.0%
2013 Q4	-3.89 Million EUR	0.0%
2013 Q2	-4.28 Million EUR	0.0%
2013 FY	-8.17 Million EUR	-58.74%
2012 Q3	-1.32 Million EUR	0.0%
2012 FY	-5.15 Million EUR	0.0%
2012 Q4	-1.32 Million EUR	0.0%

Peer Operating Income Comparison of Nanobiotix S.A.

Name	Operating Income	Operating Income Difference
Boiron SA	42.29 Million EUR	163.322%
Laboratorios Farmaceuticos Rovi, S.A.	220.25 Million EUR	112.158%
Vetoquinol SA	74.26 Million EUR	136.059%
Valneva SE	-82.08 Million EUR	67.377%
AB Science S.A.	-13.42 Million EUR	-99.412%
PHAXIAM Therapeutics S.A.	-23.66 Million EUR	-13.183%
Vivoryon Therapeutics N.V.	-28.83 Million EUR	7.137%
BioSenic S.A.	-7.04 Million EUR	-280.384%
ABIVAX Société Anonyme	-127.37 Million EUR	78.976%
Formycon AG	-369 Thousand EUR	-7157.182%